Mounjaro UK Price Guide 2025: Cheaper Alternatives

What is Mounjaro?

Eli Lilly has developed Mounjaro (tirzepatide), a groundbreaking drug that manages type 2 diabetes and also has significant weight loss effects. Unlike many other medications, Mounjaro targets two receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual action helps regulate blood sugar levels, control appetite, and support sustainable weight management.

Why choose Ashcroft Pharmacy?

Ashcroft Pharmacy is one of the fully licensed, reliable, and trustworthy pharmacies in the UK, offering:

• Fast shipping
• Expert guidance to maximise results
• Affordable rates 

 

Factors affecting Mounjaro cost in the UK?

Mounjaro cost depends on these factors:

Provider type

Each provider or pharmacy has set different prices, with some online clinics offering discounts or subscription plans. To find the lowest rates, check comparison sites.

Dosage 

The dose of Mounjaro you're prescribed can impact the cost, with higher strengths typically having a higher price tag. It's worth discussing with your healthcare provider whether a lower dose might be effective for you. This could be a way to manage costs while still getting the necessary treatment.

Support included

Some providers include extra support services such as habit-change coaching, dietitian support, progress tracking, and structured guidance, influencing the overall price. The private monthly cost of Mounjaro at Ashcroft Pharmacy is approximately:

The private monthly cost of Mounjaro at Ashcroft pharmacy is:

• Lowest dose (2.5 mg -1 Pen): £149.99
• Highest dose (15 mg -1 Pen): £294.99

NHS PRESCRIPTIONS 

Mounjaro (tirzepatide) is being rolled out on the NHS in phases, with the initial group of eligible patients meeting specific criteria.

Eligibility Criteria - Phase 1

Patients must meet criteria related to BMI and Long-term Conditions:

BMI: 

• A body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for individuals from certain Black, Asian, and minority ethnic backgrounds).

Long-term Conditions:

Presence of at least four of the following five weight-related health conditions:

• Diagnosed type 2 diabetes.
• High blood pressure requiring medication.
• Dyslipidaemia (abnormal fat levels in the blood).
• Established Cardiovascular Disease (e.g., heart disease, stroke, or vascular disease).
• Obstructive Sleep Apnoea (with a confirmed diagnosis).

Phased Rollout:

The NHS is introducing Mounjaro in phases. It starts with those meeting the strictest criteria (Cohort 1, expected from June 2025), with broader eligibility planned for subsequent years (Cohorts 2 and 3). Currently, GPs are identifying eligible patients through health records and contacting them directly. They will be referred to specialist weight management services.

What are the options for continuing weight loss treatment given Mounjaro price increases?

The three main paths to consider:

Continue on Mounjaro

If the higher cost isn't an issue for you, you can stick with Mounjaro. Some providers offer loyalty discounts, subscriptions, or frozen prices to ease the financial burden.

Stay on your current dose

If your current dose is working well, you could choose not to move to higher, more expensive strengths. Sticking to a lower dose is often more affordable and can help maintain the benefits already achieved.

Switch to a new treatment 

If the new Mounjaro price is a concern, or if Mounjaro is no longer the right treatment for you, consider alternative weight loss treatments. Options include Wegovy, Orlistat, or others. These medications may offer similar weight loss and diabetes management benefits, potentially at a lower price point. A consultation with your prescriber can help you navigate these options effectively.

Will Mounjaro get cheaper?

Eli Lilly has raised Mounjaro prices to align with the European market. Therefore, it is unlikely to get cheaper privately in the UK. Although the NHS offers it at a subsidised cost for eligible patients, private prices are expected to remain high. Therefore, the main opportunities for savings currently come from NHS access or exploring alternative treatments like Wegovy or Mysimba.

Mounjaro vs other weight loss treatments — Affordable alternatives 

If you want to switch from Mounjaro to other GLP-1 treatments, the options are:

Wegovy (semaglutide) 

Wegovy (semaglutide) is administered once weekly and helps with weight management by reducing appetite and enhancing feelings of fullness.

• Effectiveness: Wegovy helps people lose weight by around 17.4% (over 68 weeks), especially when combined with diet and exercise.
• Monthly Cost in UK: Wegovy costs around £120-£225 per month, offering a budget-friendly alternative to those finding Mounjaro expensive.

Saxenda (liraglutide)

Saxenda is an analogue of the GLP-1 hormone and is administered once a day. It contains liraglutide as the active ingredient. This suppresses appetite, promotes feelings of fullness, and leads to weight loss when combined with diet and exercise.

• Efficacy: Clinical trials show that 86 percent of users have lost some weight, three out of five individuals have lost about 5 percent of their body weight, and one out of three individuals has lost over 10 percent of their body weight after 56 weeks.
• Saxenda UK Price: Saxenda costs £69.99 for 1 pen and £349.99 for 5 pens.

Orlistat 

Orlistat is a prescription weight loss medication that works by inhibiting the digestive lipase enzyme and reducing fat absorption by up to 30% when taken with meals. It is sold under the brand name Xenical and is also available over the counter under the name Alli. It works best when combined with a calorie-controlled, low-fat diet and exercise regimen.

• Efficacy: Studies showed that 35% of Orlistat users achieved >5% weight loss compared to 21% of placebo users. Additionally, 28% of Orlistat users achieved >10% weight loss compared to 17% in the placebo group.
• Orlistat Price UK: Orlistat costs around £33.98 monthly.

Mysimba Tablet

Mysimba is the combination of bupropion and naltrexone, which helps manage chronic obesity in adults, alongside diet and physical activity. It is a prescription drug in the UK and acts by blocking reward systems and controlling appetite, supporting weight loss.

• Efficacy: A meta-analysis found that individuals using Mysimba were twice as likely to lose 5% of their weight compared to placebo.
• Mysimba Price UK: Mysimba will cost £109 for 112 tablets.

 

Be careful of counterfeit Mounjaro sales

The surge in fake Mounjaro pens in the UK is indeed alarming, especially with the rising prices of the genuine medication. Counterfeit pens pose serious health risks. They might contain incorrect or harmful ingredients, or be stored improperly, making them potentially dangerous.

Key Risks

• Incorrect ingredients: Fake pens may contain substances like insulin instead of tirzepatide, leading to severe side effects like hypoglycaemic shock or coma.
• Unknown Dosage: Counterfeit products can have incorrect dosages, making them ineffective or hazardous.
• Impurities: Some fakes can contain bacteria, risking infection.
• Health Consequences: Using fake weight loss injections has led to hospitalisations and serious side effects.

Legit Sources for Mounjaro

• Licensed Pharmacies: Look for pharmacies regulated by the General Pharmaceutical Council (GPhC) and approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
• Trusted Clinics: Ensure clinics follow strict medical guidelines.
• Prescription Requirement: Genuine Mounjaro requires a prescription from a qualified healthcare professional. (End of Article or Next Section) (Note: Assumes "Check Same Results Alternatives" button and Rybelsus/Orlistat product box follow this section)